• About us
• Contact

Advertisement

Product › Details

Cardiolite

	Next higher product group	Tetrakis kupfer-tetrafluoroborat
	Status	1992-01-01 registration start
	Organisation	DuPont Pharma GmbH
	Group	DuPont (Group)

Record changed: 2023-07-10

Advertisement

More documents for pharmaceutical_o

• [1] Angelini Pharma S.p.A.. (5/7/26). "Press Release: Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease". Rome & Coral Gable...
• [2] Scarlet Therapeutics Ltd.. (5/7/26). "Press Release: Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood". Bristol....
• [3] Suzhou Siran Biotechnology Co., Ltd.. (5/6/26). "Press Release: SiranBio and GSK Enter License Agreement for Oligonucleotide Candidate Targeting Metabolic and Vascular Risk across Lung, Liver and Kidney Disease"....
• [4] Chiesi Farmaceutici S.p.A.. (4/29/26). "Press Release: Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio". Parma & Framingham, MA....
• [5] Santhera Pharmaceuticals Holding AG. (4/23/26). "Press Release: Santhera Appoints Orlando Oliveira as Chief Executive Officer". Pratteln....
• [6] Santhera Pharmaceuticals Holding AG. (3/10/26). "Press Release: Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth". Pratteln....
• [7] Medivir AB. (3/3/26). "Press Release: Medivir Recruits Patrik Norgren as New CFO". Stockholm....
• [8] Madrigal Pharmaceuticals, Inc.. (2/11/26). "Press Release: Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs". Conshohocken, PA....
• [9] Swedish Orphan Biovitrum AB. (12/13/25). "Press Release: Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout"....
• [10] Booster Therapeutics GmbH. (11/23/25). "Press Release: Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study". Be...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.